composition for coating or matrix with delayed release and nmda receptor antagonists and methods for administration of an nmda receptor antagonist to a subject of such

摘要

PharmaceuticalComposition, memantine or a pharmacologically acceptable saltof which and a component fora delayedRelease includes, for use in oral administrationto achieve therapeutically effective plasma equilibrium concentrationof memantine or a pharmacologically acceptable salt thereof in a human beingwithin 15 days of initiation of therapy with memantineor a pharmacologically acceptableSalt of it.